Light Therapy Device Market is expected to grow at a CAGR of 3.7% during the forecast period (2026-2033).
Light therapy, also known as phototherapy, is a medical treatment involving using an artificial light source. The therapy is primarily used to treat seasonal major depressive disorder (MDD) (formerly known as seasonal affective disorder, or SAD).
Light Therapy Device Market Dynamics
- Rising demand for home-based wellness and self-care solutions is emerging as a key growth driver for the global light therapy device market, as consumers increasingly seek convenient, preventive, and non-invasive ways to manage physical and mental well-being outside traditional clinical settings. The shift is closely linked to growing pressure on healthcare systems and a broader redefinition of personal care as an integral component of overall health rather than discretionary beauty spending.
- For instance, the Global Self-Care Federation (GSCF) highlights the economic and systemic impact of self-care, showing that existing self-care practices already generate over $119 billion in annual global savings and free up nearly 1.8 billion physician hours, underscoring the value of scalable at-home interventions. In contrast, traditional beauty markets are experiencing slower expansion, with overall beauty growth cooling to around 4.5% in 2024, while wellness continues to grow at more than twice the pace, indicating a structural shift in consumer priorities toward health-led solutions.
- Additionally, consumer perception is also evolving rapidly. A recent Kenvue study found that 88% of global consumers believe their personal care routines positively affect their health, reinforcing demand for products that deliver measurable wellness outcomes. Importantly, consistent but time-efficient routines—often under 30 minutes daily—are gaining traction, aligning well with light therapy devices that offer quick, repeatable, and low-effort treatment sessions at home.
- Looking ahead, continued investment in self-care education, rising acceptance of preventive health tools, and expanding access in emerging markets are expected to further accelerate adoption of home-use light therapy devices.
Light Therapy Device Market Segment Analysis
- The red light segment is a major growth driver in the global light therapy device market due to its expanding use in pain management, muscle recovery, skin rejuvenation, and wound healing.
- Red light therapy, typically operating in the 620–660 nm wavelength range, is widely associated with photobiomodulation benefits that stimulate cellular energy (ATP) production and reduce inflammation. Clinically, red light has shown measurable outcomes in chronic pain reduction, joint stiffness improvement, and post-exercise recovery, making it attractive for both medical and home-use applications. Industry estimates indicate that red and near-infrared light devices together account for over one-third of new product launches in the light therapy space.
- In dermatology, red light is increasingly used for anti-ageing and acne management, with studies reporting visible skin texture and wrinkle improvement after consistent multi-week use. Consumer adoption is accelerating as red light devices are non-invasive, drug-free, and suitable for short daily sessions, aligning with modern self-care routines.
- Commercially, several FDA-cleared devices now integrate red light modes for pain and skin indications, enhancing clinical credibility. Fitness and physiotherapy centers are also incorporating red light panels to support recovery protocols. Technological advances in high-efficiency LEDs and portable panels have reduced device costs, expanding accessibility.
Light Therapy Device Market
| Metrics | Details |
| Market CAGR | 3.7% |
| Segments Covered | By Product Type, By Light Type, By Application, and By Region |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
| Fastest Growing Region | Asia Pacific |
| Largest Market Share | North America |
Light Therapy Device Market Geographical Analysis
The rising incidence of psoriasis and seasonal affective disorder in this region is expected to drive the light therapy devices market. For instance, according to current research, more than 8 million people in the United States have psoriasis. According to the World Psoriasis Day consortium, 125 million people worldwide, 2 to 3% of the total population, have psoriasis. Psoriasis affects approximately 2.2 per cent of the population (7.5 million people) in the United States, making it the most common autoimmune disease.
Moreover, seasonal affective disorder affects about 5% of adults in the United States. It usually begins in adolescence. Women account for approximately 75% of those who suffer from seasonal affective disorder. A milder form of the winter blues may affect 10% to 20% of people in the United States. Phototherapy using a special lamp, bright light therapy can treat SAD.
Hence, with the growing incidence of psoriasis and seasonal affective disorder, the demand for light therapy or phototherapy is expected to increase in the forecast period.
Light Therapy Device Market Competitive Landscape
The global light therapy device market is moderately competitive with increasing acquisitions, mergers and launches. Some key players in the market are Northern Light Technologies, Verilux, Inc, Koninklijke Philips N.V., Beurer, AuraDayLight, NatureBright, Lucimed SA, Lumie, Dr Müller, GlobalMed Technologies.
GlobalMed Technologies
Overview: GlobalMed Technologies (GMT) was founded in 1996. It is a global medical technology company in Northern California's Bay Area. Specializing in lasers and other complex energy-based systems to treat various medical and cosmetic conditions, GlobalMed has represented and launched some of the industry's most recognisable brands, including VASER, BTL, Cool Touch, PhotoMedex, Radiancy, and Omnilux, over its 20-year history. GMT is present in over 45 countries and has direct regional managers in Europe and the Middle East.
Product Portfolio: Omnilux is the industry standard for non-thermal phototherapy skin treatment. The company manufactures Omnilux blue, Omnilux revive2, Omnilux plus.
Key Development: On July 15, 2021, GlobalMed Technologies (GMT) launched the Omnilux Contour line of home-use LED light therapy products in Australia and New Zealand. Contour products, the only line of home-use LED devices based on the gold standard Omnilux Medical professional light therapy system, are now available to consumers and skincare professionals in Australia and New Zealand via Omnilux online store.
Frequently Asked Questions
What is the Projected CAGR value of the Light Therapy Device Market?
Light Therapy Device Market is expected to grow at a CAGR of 3.7% during the forecasting period 2026-2033.
Which region controlled the global market during 2022-2033?
North America region Controls the Light Therapy Device Market during 2022-2029
Which is the fastest growing region in the Light Therapy Device Market?
Among all regions, Asia Pacific is the fastest growing market share during the forecast period
